Think10

www.Think-10.com is a life science business consultancy, a personal coaching and team development to all businesses and a service to the pharmaceutical industry to facilitate change,

Melanie Lee PhD, CBE, FMedSci, DSc(Hons)

LifeArc

Chief Executive Officer

Principal CEO

BTGplc

BTG plc is a fast growing exciting Interventional Medicine company - on the international stage with it's HQ in London. We have device and drug combination products in the Interventional vascular and oncology space and have recently entered the Interventional Pulmonary area with the acquisition of PneuMRx and their innovative coiled device to treat emphysema patients. Interventional medicine routes to the market place in the hands of skilled physicians is likely to be relevant to many of the emerging new modalities in the pipelines of our innovative biotechs today.

Chief Scientific Officer

NightstaRx Ltd

NightstaRx is a Syncona backed company established to pursue the gene therapy treatment of Choroideremia to prevent the deterioration of eyesight in patients with this X-linked disease which causes loss of sight during the mid 40-50 years of life. Early clinical studies by Robert MacLaren have shown promising efficacy and good safety. The therapy for this indication is to replace the faulty REP1 gene in the eye with a functioning copy in an AAV vector. NightstaRx aims to gain regulatory approval for this therapy with ensuring GMP of the product and agreeing the pivotal clinical path. Www.nightstarx.co.uk

NED (was Founding CEO during 2014)

Syntaxin Ltd

Syntaxin was a successful biotech spun out of the HPA that was developed by myself and my management team, with the help if course of our excellent scientists, to a stage for acquisition to ensure the further investment in the recombinant botulinum toxin technology. Ipsen acquired Syntaxin in July 2013 and the site continues as Ipsen's centre for toxin engineering, complementing well the Ipsen expertise in toxin biology. I left Syntaxin with the acquisition and now work through Think10 as I discuss new opportunities.

Chief Executive officer

EVP and President UCB NewMedicines

Breast Cancer Haven

Angel

Applied Genomics Link Scheme

Working to award funds to innovate collaborative programmes between strong academic groups and small companies.

Chairman

Celltech

EVP R&D, Celltech

Glaxo

Unit Head

I'm a passionate leader dedicated to driving innovation and positive impact in the life sciences industry.🔬

Throughout my career, I have championed the translation of scientific knowledge into impactful healthcare solutions and am passionate about fostering an environment that encourages multidisciplinary collaboration, nurtures scientific talent, and supports the next generation of innovators.

I actively engage with industry leaders, policymakers, and research institutions to shape the future of the life sciences ecosystem.

By participating in conferences, thought leadership activities, and industry forums, I strive to drive positive change and advance the boundaries of medical research.

I am always excited to speak with like-minded professionals, researchers, and individuals passionate about making a difference in healthcare. ⬇️

Let's amplify our impact in healthcare by connecting and collaborating towards a brighter future.🧑🏻‍🔬

Melanie Lee

Experienced manager with ~20 years experience in innovation, data, business management and strategy in CPG and Pharma with leading edge expertise in digital, AI, tech, analytics. 

By day, I drive transformation for Sanofi in UK and Ireland, accelerating patient care with data and AI.

By night, I run the registered charity Eyes on the Future to save my daughter Vicky’s sight and that of many others’ affected by ultra rare eye diseases.

My Superpower: Creating waves and making magic happen through connections, collaboration and innovation. 

My Belief: I believe in a world where everybody deserves a treatment for their disease no matter how rare, expensive and difficult. 

Eyes on the Future Achievements so far: 
- Seeded science all over the world. Raised over 2 Million $ personally and 5 Million $ as a community to support preclinical research on RDH12 Inherited Retinal Dystrophies.
- Fostered collaboration and scientific progress: first ever scientific conference, first ever scientific landscape and first ever global patient day. 
- Created a community of patients from 20+ countries worldwide affected by the same ultra rare condition. 
- Affiliation and partnership with leading medical and eye charities (Eurordis, LifeArc, Retina International, Global Genes…)
-Efforts covered by press internationally from BBC, Forbes, Vanity Fair, London Evening Standard, the Huffington Post, Corriere della Sera and more.  

taplio

The Battle

Melanie Lee

Silvia Cerolini

Followers

Posts

Engagements

Likes

Ready to grow your LinkedIn presence?